首页|β受体阻滞剂普萘洛尔介导VCAM1调节NF-κB信号通路改善大鼠缺血性心肌病

β受体阻滞剂普萘洛尔介导VCAM1调节NF-κB信号通路改善大鼠缺血性心肌病

扫码查看
目的 通过构建缺血性心肌病(ischemic cardio myopathy,ICM)大鼠模型,探讨普萘洛尔是否通过调节VCAM1/NF-κB信号通路改善ICM.方法 将50只SD大鼠随机分为对照组(Control组)、缺血性心肌病组(ICM组)、普萘洛尔组(Propranolol组)、普萘洛尔+过表达对照组(Propranolol+ov-NC组)和普萘洛尔+过表达VCAM1组(Propranolol+ov-VCAM1组),每组10只.RT-qPCR检测大鼠心肌组织VCAM1 mRNA表达;Western blot检测大鼠心肌组织VCAM1、p-NF-κB和NF-κB蛋白表达;HE染色观察大鼠心肌组织病理形态变化;Masson染色观察大鼠心肌组织纤维化程度;免疫荧光观察大鼠心肌M1/M2型巨噬细胞比例;ELISA检测大鼠心肌组织IL-1β、IL-6和IL-10含量.结果 对照组大鼠心肌纤维排列整齐,心肌间质未见水肿,心肌中几乎无胶原纤维分布;ICM组大鼠心肌可见纤维排列紊乱、间质水肿以及大量分布不均的胶原纤维;普萘洛尔组和普萘洛尔+ov-NC组大鼠心肌损伤和纤维化改善;普萘洛尔+ov-VCAM1组大鼠心肌损伤和纤维化较普萘洛尔组和普萘洛尔+ov-NC组加重.与对照组相比,ICM组大鼠心肌组织中VCAM1 mRNA和蛋白表达以及NF-κB磷酸化水平显著升高M1型巨噬细胞比例以及IL-1β和IL-6含量显著升高,M2型巨噬细胞比例以及IL-10含量显著降低;与ICM组相比,Propranolol组和Propranolol+ov-NC组大鼠心肌组织中VCAM1 mRNA和蛋白表达以及NF-κB磷酸化水平显著降低,M1型巨噬细胞比例以及IL-1β和IL-6含量显著降低,M2型巨噬细胞比例以及IL-10含量显著升高;与Propranolol组和Propranolol+ov-NC组相比,Propranolol+ov-VCAM1组大鼠心肌组织中VCAM1 mRNA和蛋白表达以及NF-κB磷酸化水平显著升高,M1型巨噬细胞比例以及IL-1β和IL-6含量显著升高,M2型巨噬细胞比例以及IL-10含量显著降低.结论 普萘洛尔治疗通过下调VCAM1表达改善ICM大鼠心肌损伤和纤维化,其机制可能与抑制NF-κB磷酸化介导的M1型巨噬细胞极化有关.
β-blocker propranolol mediates VCAM1 to regulate NF-κB signaling pathway to improve rats with ischemic cardiomyopathy
Objective To establish a rat model of ischemic cardiomyopathy(ICM),to explore whether propranolol can improve the ICM by regulating VCAM1/NF-κB signaling pathway.Methods Fifty SD rats were randomly divided into Control group(control group),ischemic cardiomyopathy group(ICM group),Propranolol group(Propranolol group),propranolol+overexpression control group(Propranolol+ov-NC group)and propranolol+overexpression VCAM1 group(Propranolol+ov-VCAM1 group),with 10 rats in each group.RT-qPCR was used to detect the expression of VCAM1 mRNA in rat myocardial tissue;Western blot was used to detect the expression of VCAM1,p-NF-κB and NF-κB protein in rat myocardium.HE staining was used to observe the pathological changes of myocardial tissue in rats.Masson staining was used to observe the degree of myocardial fibrosis in rats.The ratio of M1/M2 macrophages in rat myocardium was observed by immunofluorescence.The contents of IL-1β,IL-6 and IL-10 in myocardial tissue of rats were detected by ELISA.Results In the control group,the myocardial fibers were arranged neatly,no edema was found in the myocardial interstitium,and almost no collagen fibers were distributed in the myocardium.In ICM group,there were disordered fiber arrangement,interstitial edema and a large number of uneven collagen fibers in the myocardium of rats.Myocardial injury and fibrosis were improved in propranolol group and propranolol+ov-NC group.Myocardial injury and fibrosis in propranolol+ov-VCAM1 group were more serious than those in propranolol group and propranolol+ov-NC group.Compared with the control group,the expression of VCAM1 mRNA and protein and the phosphorylation level of NF-κB in the myocardial tissue of rats in ICM group increased significantly,and the proportion of M1-type macrophages and the contents of IL-1β and IL-6 increased significantly,while the proportion of M2-type macrophages and the content of IL-10 decreased significantly.Compared with ICM group,the expression of VCAM1 mRNA and protein and the phosphorylation level of NF-were arranged neatly,no edema was found in tl group and Propranolol+ov-NC group decreased significantly,while the proportion of M1 type macrophages and the contents of IL-1β and IL-6 decreased significantly,while the proportion of M2 type macrophages and the content of IL-10 increased significantly.Compared with Propranolol group and Propranolol+ov-NC group,the expression of VCAM1 mRNA and protein and the phosphorylation level of NF-κB in myocardial tissue of rats in Propranolol+ov-VCAM1 group increased significantly,while the proportion of M1 type macrophages and the contents of IL-1β and IL-6 increased significantly,while the proportion of M2 type macrophages and the content of IL-10 decreased significantly.Conclusion Propranolol treatment can improve myocardial injury and fibrosis in ICM rats by down-regulating VCAM1 expression,and its mechanism may be related to inhibiting the polarization of M1 macrophages mediated by NF-κB phosphorylation.

ICMBeta-blockersPropranololM1/M2 macrophage imbalanceVCAM1NF-κB signaling pathway

李利、胡娜、蒋志明、杨晓芳、李良义

展开 >

410000,长沙市第四医院滨水新城院区心血管内科

410000,长沙市第四医院滨水新城院区科教科

缺血性心肌病 β受体阻滞剂 普萘洛尔 M1/M2巨噬细胞失衡 VCAM1 NF-κB信号通路

2024

免疫学杂志
第三军医大学,中国免疫学会

免疫学杂志

CSTPCD
影响因子:0.704
ISSN:1000-8861
年,卷(期):2024.40(7)